About 39% of people in the United States have utilized these substances for therapeutic purposes, spurring investigation into their potential for preventing and treating some diseases.
Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.
Patients who undergo a kidney transplant may face limitations in treatment options for diabetes mellitus because of the uncertainty of their renal function post transplantation.
Awareness of a patient’s potential procedures and changes in nutritional intake enables the pharmacist to prevent hypoglycemic events by proactively adjusting the insulin regimen.